Roquefort Therapeutics
Business Services · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
85 Great Portland St Fl 1, London, Great...Phone Number
+44 2039188633Website
www.roquefortplc.comRevenue
<$5 MillionStock Symbol
ROQIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Roquefort Therapeutics
Roquefort Therapeutics plc, a material biotech company, engages in the development of medicines for the treatment of cancer. Its product portfolio consists of five novel patent-protected pre-clinical anti-cancer medicines, which include Midkine antibodies with significance in vivo efficacy and toxicology studies, as well as orphan drug indication; Midkine RNA oligonucleotide therapeutics with novel anti-cancer gene editing action; Midkine mRNA therapeutics for solid tumors; STAT-6 siRNA therapeutics targeting solid tumors with significance in vivo efficacy; and MK cell therapy with direct and natural killer cell-mediated anti-cancer action.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Roquefort Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Roquefort Therapeutics launches new products
Funding: Get notified immidiatlly once Roquefort Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Roquefort Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Roquefort Therapeutics is spiking on competitors!
Click to see if Roquefort Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Roquefort Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Roquefort Therapeutics
Check if Roquefort Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Roquefort Therapeutics
Find 3 more new buyers
Compare Similar Companies to Roquefort Therapeutics
Compare insights from companies similar to Roquefort Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Roquefort Therapeutics
<$5M
1-10
Public
-
2020
N/A
Company Profile Activity
Activity Insights
Roquefort Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Roquefort Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Roquefort Therapeutics.
Roquefort Therapeutics Tech Stack
A closer look at the technologies used by Roquefort Therapeutics
See more technologies
Roquefort Therapeutics News & Media
Roquefort Therapeutics plc - Special Call
Roquefort Therapeutics plc - Special CallCompany ParticipantsStephen West - Executive ChairmanEdward Painter - Co-Founder, Chairman & CIOSridhar Vempati...
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Roquefort Therapeutics
Sign Up For FreeTo access detailed company insights
Roquefort Therapeutics plc, a material biotech company, engages in the development of medicines for the treatment of cancer. Its product portfolio consists of five novel patent-protected pre-clinical anti-cancer medicines, which include Midkine antibodies with significance in vivo efficacy and toxicology studies, as well as orphan drug indication;... Read More
